Nataliia L. Sheremet
Research Subjects
Nataliia L. Sheremet has a total of 264 co-authors. Here are the top co-authors by number of shared publications:
- Irina A. Ronzina
Krasnov Research Institute of Eye Diseases
16 shared publications - Andrey Yurevich Andreev
Krasnov Research Institute of Eye Diseases
14 shared publications - Tatiana D. Krylova
Research Centre for Medical Genetics, 115522 Moscow, Russia
13 shared publications - Yu. K. Murakhovskaya
Krasnov Research Institute of Eye Diseases
13 shared publications - Polina G. Tsygankova
Research Centre for Medical Genetics, 115522 Moscow, Russia
11 shared publications G S Polunin
10 shared publications
Latest Publications
- 29 June 2026
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 142 (3) , 101-109
Non-glaucomatous optic nerve atrophy: epidemiology, etiological structure, and clinical diagnostic features
Non-glaucomatous optic nerve atrophy (ONA) is a polyetiological pathological condition characterized by the loss of retinal ganglion cell axons and structural changes in the optic nerve head. ONA is one of the leading causes of irreversible visual impairment and disability across different age groups. This review presents current data on the epidemiology, clinical and demographic characteristics, pathogenesis, classification, diagnosis, treatment, and prognosis of ONA.
- 29 June 2026
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 142 (3) , 101-109
Non-glaucomatous optic nerve atrophy: epidemiology, etiological structure, and clinical diagnostic features
Non-glaucomatous optic nerve atrophy (ONA) is a polyetiological pathological condition characterized by the loss of retinal ganglion cell axons and structural changes in the optic nerve head. ONA is one of the leading causes of irreversible visual impairment and disability across different age groups. This review presents current data on the epidemiology, clinical and demographic characteristics, pathogenesis, classification, diagnosis, treatment, and prognosis of ONA.
- 28 April 2026
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 142 (2) , 50-55
Clinical case of an inherited retinal disease with late manifestation
Rod-cone dystrophy (RCD) is one of the forms of inherited retinal diseases (IRDs) caused by photoreceptor degeneration and leading to significant loss of visual function. In some cases, patients with late-onset RCD do not independently report complaints typical of IRDs, and standard and additional ophthalmological examinations performed using conventional methods fail to reveal pathological changes, which complicates and delays diagnosis. This article presents a case of late-onset RCD diagnosed through the active identification of characteristic complaints, thorough medical history taking, and targeted use of modern functional and structural retinal imaging techniques with an extended visualization range.
- 28 April 2026
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 142 (2) , 50-55
Clinical case of an inherited retinal disease with late manifestation
Rod-cone dystrophy (RCD) is one of the forms of inherited retinal diseases (IRDs) caused by photoreceptor degeneration and leading to significant loss of visual function. In some cases, patients with late-onset RCD do not independently report complaints typical of IRDs, and standard and additional ophthalmological examinations performed using conventional methods fail to reveal pathological changes, which complicates and delays diagnosis. This article presents a case of late-onset RCD diagnosed through the active identification of characteristic complaints, thorough medical history taking, and targeted use of modern functional and structural retinal imaging techniques with an extended visualization range.
- 23 December 2025
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 141 (6) , 109-113
Transient visual loss in morning glory syndrome
The causes of monocular transient visual loss (TVL) are diverse, necessitating a careful approach to diagnosis and differential evaluation of multiple conditions. In rare cases, TVL may occur in association with optic disc anomalies such as morning glory syndrome (MGS), coloboma, or optic disc drusen. The purpose of this article is to present a clinical case of TVL in a patient with MGS. A 25-year-old patient reported experiencing TVL in the left eye over the past 3—4 years, triggered by physical exertion, straining, or visual tasks requiring concentration. Ophthalmoscopy revealed MGS in the left eye, as well as exercise-induced contractile movements of the optic disc accompanied by TVL. Ultrasonography revealed an avascular hyperechoic structure displacing the central retinal artery and vein laterally, which likely contributed to compromised blood flow in the posterior segment of the eye and the occurrence of TVL. The optic nerve changes causing TVD were found to be local and unrelated to systemic status.
- 23 December 2025
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 141 (6) , 109-113
Transient visual loss in morning glory syndrome
The causes of monocular transient visual loss (TVL) are diverse, necessitating a careful approach to diagnosis and differential evaluation of multiple conditions. In rare cases, TVL may occur in association with optic disc anomalies such as morning glory syndrome (MGS), coloboma, or optic disc drusen. The purpose of this article is to present a clinical case of TVL in a patient with MGS. A 25-year-old patient reported experiencing TVL in the left eye over the past 3—4 years, triggered by physical exertion, straining, or visual tasks requiring concentration. Ophthalmoscopy revealed MGS in the left eye, as well as exercise-induced contractile movements of the optic disc accompanied by TVL. Ultrasonography revealed an avascular hyperechoic structure displacing the central retinal artery and vein laterally, which likely contributed to compromised blood flow in the posterior segment of the eye and the occurrence of TVL. The optic nerve changes causing TVD were found to be local and unrelated to systemic status.
- Open Access
- 10 May 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (10) , 4565
Exploring the Phenotypic Heterogeneity and Bioenergetic Profile of the m.13513G>A mtDNA Substitution: A Heteroplasmy Perspective
The m.13513G>A (p.Asp393Asn) substitution in the MT-ND5 (Mitochondrially Encoded NADH/Ubiquinone Oxidoreductase Core Subunit 5) gene is a common pathogenic variant associated with primary mitochondrial disorders. It frequently causes Leigh syndrome and mitochondrial encephalomyopathy with lactate acidosis and stroke-like episodes (MELAS). In this study, we present clinical data, heteroplasmy levels in various tissues (blood, urine, and skin fibroblasts), and bioenergetic characteristics from a cohort of 20 unrelated patients carrying the m.13513G>A mutation, classified according to the following phenotypes: Leigh syndrome (n = 12), MELAS (n = 2), and Leber’s hereditary optic neuropathy (LHON, n = 6). We observed a significant correlation between high respiratory ratios and heteroplasmy levels in fibroblast cell lines of the patients. Furthermore, fibroblast cell lines with heteroplasmy levels exceeding 55% exhibited markedly reduced mitochondrial membrane potential. These findings contribute to a better understanding of the clinical and bioenergetic profiles of patients with m.13513G>A-variant-related phenotypes across different heteroplasmy levels, based on data from a single genetic center. Our data suggest that even a slight shift in heteroplasmy can improve cellular function and, consequently, the patients’ phenotype, providing a solid foundation for the development of future gene therapies for mtDNA diseases.
- 10 May 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (10) , 4565
Open AccessExploring the Phenotypic Heterogeneity and Bioenergetic Profile of the m.13513G>A mtDNA Substitution: A Heteroplasmy Perspective
The m.13513G>A (p.Asp393Asn) substitution in the MT-ND5 (Mitochondrially Encoded NADH/Ubiquinone Oxidoreductase Core Subunit 5) gene is a common pathogenic variant associated with primary mitochondrial disorders. It frequently causes Leigh syndrome and mitochondrial encephalomyopathy with lactate acidosis and stroke-like episodes (MELAS). In this study, we present clinical data, heteroplasmy levels in various tissues (blood, urine, and skin fibroblasts), and bioenergetic characteristics from a cohort of 20 unrelated patients carrying the m.13513G>A mutation, classified according to the following phenotypes: Leigh syndrome (n = 12), MELAS (n = 2), and Leber’s hereditary optic neuropathy (LHON, n = 6). We observed a significant correlation between high respiratory ratios and heteroplasmy levels in fibroblast cell lines of the patients. Furthermore, fibroblast cell lines with heteroplasmy levels exceeding 55% exhibited markedly reduced mitochondrial membrane potential. These findings contribute to a better understanding of the clinical and bioenergetic profiles of patients with m.13513G>A-variant-related phenotypes across different heteroplasmy levels, based on data from a single genetic center. Our data suggest that even a slight shift in heteroplasmy can improve cellular function and, consequently, the patients’ phenotype, providing a solid foundation for the development of future gene therapies for mtDNA diseases.
- Open Access
- 1 May 2025
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 63 (2) , 146-157
Uveitis in spondyloarthritis: current possibilities of anti-inflammatory therapy
Uveitis is a common extra-skeletal manifestation of ankylosing spondylitis (AS) and other spondyloarthritis (SpA). The recurrent course of uveitis in SpA contributes to the development of complications affecting vision. Timely treatment of uveitis exacerbation and prevention of relapses is an important component of SpA management. The article discusses approaches to modern anti-inflammatory therapy of uveitis in SрA, including traditional and targeted drugs. The data from clinical studies on the effect of various treatment regimens on the course of uveitis in SpA are presented, as well as a comparative assessment of the effectiveness of biologic and targeted synthetic drugs.
- 1 May 2025
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 63 (2) , 146-157
Open AccessUveitis in spondyloarthritis: current possibilities of anti-inflammatory therapy
Uveitis is a common extra-skeletal manifestation of ankylosing spondylitis (AS) and other spondyloarthritis (SpA). The recurrent course of uveitis in SpA contributes to the development of complications affecting vision. Timely treatment of uveitis exacerbation and prevention of relapses is an important component of SpA management. The article discusses approaches to modern anti-inflammatory therapy of uveitis in SрA, including traditional and targeted drugs. The data from clinical studies on the effect of various treatment regimens on the course of uveitis in SpA are presented, as well as a comparative assessment of the effectiveness of biologic and targeted synthetic drugs.
- Open Access
- 22 December 2024
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 21 (4) , 643-649
Retinal Migraine: from History to the Present Day
Retinal migraine is a rare migraine variant, initially described in 1882 as ‘ophthalmic megrim’. Since then, various terms have been used in the literature, such as “ocular migraine”, “monocular migraine”, and “migraine of the anterior visual pathway”. The lack of an unified definition led to controversy and potential confusion in defining the diagnosis. Later, the International Classification of Headache Disorders (ICHD-3) defined retinal migraine as repeated attacks of monocular visual disturbance, including scintillation, scotoma or blindness, associated with migraine headache, which are fully reversible. Retinal migraine should be considered a diagnosis of exclusion that requires ruling out other causes of transient monocular vision loss. The purpose of this review is to analyze the data on the prevalence, pathogenesis, clinical presentation, and differential diagnosis of retinal migraine reported in the literature.
- 22 December 2024
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 21 (4) , 643-649
Open AccessRetinal Migraine: from History to the Present Day
Retinal migraine is a rare migraine variant, initially described in 1882 as ‘ophthalmic megrim’. Since then, various terms have been used in the literature, such as “ocular migraine”, “monocular migraine”, and “migraine of the anterior visual pathway”. The lack of an unified definition led to controversy and potential confusion in defining the diagnosis. Later, the International Classification of Headache Disorders (ICHD-3) defined retinal migraine as repeated attacks of monocular visual disturbance, including scintillation, scotoma or blindness, associated with migraine headache, which are fully reversible. Retinal migraine should be considered a diagnosis of exclusion that requires ruling out other causes of transient monocular vision loss. The purpose of this review is to analyze the data on the prevalence, pathogenesis, clinical presentation, and differential diagnosis of retinal migraine reported in the literature.
- Open Access
- 22 June 2024
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 16 (3) , 52-57
Optic neuritis in various demyelinating diseases
The discovery of antibodies against aquaporin-4 (AQP4) and against myelinoligodendrocyte glycoprotein (MOG) confirmed the existence of two disease entities distinct from multiple sclerosis (MS) — neuromyelitis optica spectrum disorders (NMOSD) and myelinoligodendrocyte glycoprotein-associated disease (MOGAD). Demyelinating optic neuritis (ON) can be either idiopathic (iDON) or a manifestation of MS, NMOSD (AQP4-ON) or MOGAD (MOG-ON).Objective: to determine the clinical features of ON and to evaluate the diagnostic value of optical coherence tomography (OCT) in demyelinating diseases of the central nervous system.Material and methods. The study included 43 patients with demyelinating ON who were divided into three groups according to the underlying disease (NMOSD, MOGAD and MS/iDON). We assessed visual acuity (VA) in the acute phase and analyzed VA and average values of retinal nerve fiber layer thickness (RNFL) and retinal ganglion cell complex (RGC) thickness using OCT data 6 months after the onset of ON.Results. ON was observed in the onset of the disease in 75% of NMOSD patients, 62% of MOGAD patients and 86% of MS/iDON patients. In the MOGAD and NMOSD groups, bilateral ON was predominantly observed. In 65% of patients with MOGAD (MOG-ONr), a recurrent course of ON was observed. VA was significantly lower in patients with AQP4-ON in acute phase and comparable to the MOG-ONr group in the long-term phase. VA in the onset of MOG-ON with a single episode was comparable to that of MS/iDON (p=0.2), but recovery was less pronounced (p=0.03). The most significant thinning of the RNFL and RGC complex was observed in the AQP4-ON and MOG-ONr groups. In AQP4-ON and MOG-ON groups, restoration of VA up to 0.5 and higher was observed significantly more frequently in the group of patients receiving pulse therapy with glucocorticoids (p=0.018).Conclusion. The study showed the most pronounced structural and functional disturbances in the long-term phase of AQP4-ON and MOG-ONr. MOG-ON was characterized by a high frequency of relapses with the influence of this factor on VA and thinning of the retinal layers in the long-term.
- 22 June 2024
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- Vol. 16 (3) , 52-57
Open AccessOptic neuritis in various demyelinating diseases
The discovery of antibodies against aquaporin-4 (AQP4) and against myelinoligodendrocyte glycoprotein (MOG) confirmed the existence of two disease entities distinct from multiple sclerosis (MS) — neuromyelitis optica spectrum disorders (NMOSD) and myelinoligodendrocyte glycoprotein-associated disease (MOGAD). Demyelinating optic neuritis (ON) can be either idiopathic (iDON) or a manifestation of MS, NMOSD (AQP4-ON) or MOGAD (MOG-ON).Objective: to determine the clinical features of ON and to evaluate the diagnostic value of optical coherence tomography (OCT) in demyelinating diseases of the central nervous system.Material and methods. The study included 43 patients with demyelinating ON who were divided into three groups according to the underlying disease (NMOSD, MOGAD and MS/iDON). We assessed visual acuity (VA) in the acute phase and analyzed VA and average values of retinal nerve fiber layer thickness (RNFL) and retinal ganglion cell complex (RGC) thickness using OCT data 6 months after the onset of ON.Results. ON was observed in the onset of the disease in 75% of NMOSD patients, 62% of MOGAD patients and 86% of MS/iDON patients. In the MOGAD and NMOSD groups, bilateral ON was predominantly observed. In 65% of patients with MOGAD (MOG-ONr), a recurrent course of ON was observed. VA was significantly lower in patients with AQP4-ON in acute phase and comparable to the MOG-ONr group in the long-term phase. VA in the onset of MOG-ON with a single episode was comparable to that of MS/iDON (p=0.2), but recovery was less pronounced (p=0.03). The most significant thinning of the RNFL and RGC complex was observed in the AQP4-ON and MOG-ONr groups. In AQP4-ON and MOG-ON groups, restoration of VA up to 0.5 and higher was observed significantly more frequently in the group of patients receiving pulse therapy with glucocorticoids (p=0.018).Conclusion. The study showed the most pronounced structural and functional disturbances in the long-term phase of AQP4-ON and MOG-ONr. MOG-ON was characterized by a high frequency of relapses with the influence of this factor on VA and thinning of the retinal layers in the long-term.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 140 (6) , 138-144
Peripapillary pachychoroid syndrome
Peripapillary pachychoroid syndrome (PPS) is a recently described condition, classified within the pachychoroid disease spectrum characterized by focal or diffuse thickening of the choroid due to dilation of choroidal vessels in the Haller’s layer (pachyvessels), thinning of the choriocapillaris and the Sattler’s layer, and accompanied by increased choroidal permeability and damage to the retinal pigment epithelium. Unlike other pachychoroid diseases that involve changes in the central retina, PPS presents with choroidal thickening and intra- or subretinal fluid located nasally in the macular region, near the optic disc. This review aims to summarize and analyze current data on the clinical features, pathogenesis, and treatment options for PPS found in the literature. Differentiating PPS is crucial, as its similarity to other conditions with overlapping features may lead to misdiagnosis and ineffective or inappropriate treatment.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 140 (6) , 138-144
Peripapillary pachychoroid syndrome
Peripapillary pachychoroid syndrome (PPS) is a recently described condition, classified within the pachychoroid disease spectrum characterized by focal or diffuse thickening of the choroid due to dilation of choroidal vessels in the Haller’s layer (pachyvessels), thinning of the choriocapillaris and the Sattler’s layer, and accompanied by increased choroidal permeability and damage to the retinal pigment epithelium. Unlike other pachychoroid diseases that involve changes in the central retina, PPS presents with choroidal thickening and intra- or subretinal fluid located nasally in the macular region, near the optic disc. This review aims to summarize and analyze current data on the clinical features, pathogenesis, and treatment options for PPS found in the literature. Differentiating PPS is crucial, as its similarity to other conditions with overlapping features may lead to misdiagnosis and ineffective or inappropriate treatment.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 140 (5) , 146-153
Brain magnetic resonance imaging features in Leber’s hereditary optic neuropathy
Leber’s hereditary optic neuropathy (LHON) is the most common inherited mitochondrial disease, characterized by the development of bilateral partial optic nerve atrophy. Modern neuroimaging technologies enable the acquisition of high-quality images, allowing for the evaluation of all structural components of the orbits, including the optic nerve. Consequently, the relevance of performing magnetic resonance imaging (MRI) in patients with LHON has increased. MRI is an essential tool for clarifying the topographic localization and the extent of the pathological process in LHON, both within and beyond the visual system. Correlating MRI findings with the clinical manifestations of LHON can help in predicting disease progression and assessing the effectiveness of therapy.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 140 (5) , 146-153
Brain magnetic resonance imaging features in Leber’s hereditary optic neuropathy
Leber’s hereditary optic neuropathy (LHON) is the most common inherited mitochondrial disease, characterized by the development of bilateral partial optic nerve atrophy. Modern neuroimaging technologies enable the acquisition of high-quality images, allowing for the evaluation of all structural components of the orbits, including the optic nerve. Consequently, the relevance of performing magnetic resonance imaging (MRI) in patients with LHON has increased. MRI is an essential tool for clarifying the topographic localization and the extent of the pathological process in LHON, both within and beyond the visual system. Correlating MRI findings with the clinical manifestations of LHON can help in predicting disease progression and assessing the effectiveness of therapy.
- 29 December 2023
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 139 (6) , 77-86
Long-term changes in morphological and functional parameters of the optic nerve in patients with various genetic variants of hereditary optic neuropathies
Leber’s hereditary optic neuropathy (LHON) and autosomal recessive optic neuropathy (ARON) are degenerative diseases of the optic nerve caused by mutations in nuclear or mitochondrial DNA (nDNA, mtDNA). The clinical picture of these diseases is similar, but there are some differences in how the visual functions change in patients with different molecular genetic variants of hereditary optic neuropathies (HON). PURPOSE This study evaluates the long-term changes in morphological and functional parameters in patients with different genetic variants of HON. MATERIAL AND METHODS The study included 84 patients (165 eyes) with a genetically confirmed LHON or ARON diagnosis. The patients underwent best-corrected visual acuity (VA) test, color vision (CV) examination, computerized perimetry using the program for low vision assessment, optical coherence tomography (OCT). RESULTS Over the course of the follow-up (60 months or longer) HON patients were revealed to have higher VA in c.152A>G and m.14484T>C mutations compared to mutations m.11778G>A and m.3460G>A. The final VA 0.5 or higher in patients with c.152A>G and m.14484T>C mutations in 54 and 71% of cases, and only in 6 and 13% of cases — with m.11778G>A and m.3460G>A mutations. Direct correlation was determined between minimal VA in the first year after disease onset and the final VA (K=0.67; pG and m.14484T>C mutations have better prognosis compared to LHON caused by m.11778G>A and m.3460G>A mutations. Vision recovery prognosis is worse in patients who had significant decrease of visual acuity at the disease onset. OCT findings reveal preservation of visual functions in all mutations.
- 29 December 2023
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 139 (6) , 77-86
Long-term changes in morphological and functional parameters of the optic nerve in patients with various genetic variants of hereditary optic neuropathies
Leber’s hereditary optic neuropathy (LHON) and autosomal recessive optic neuropathy (ARON) are degenerative diseases of the optic nerve caused by mutations in nuclear or mitochondrial DNA (nDNA, mtDNA). The clinical picture of these diseases is similar, but there are some differences in how the visual functions change in patients with different molecular genetic variants of hereditary optic neuropathies (HON). PURPOSE This study evaluates the long-term changes in morphological and functional parameters in patients with different genetic variants of HON. MATERIAL AND METHODS The study included 84 patients (165 eyes) with a genetically confirmed LHON or ARON diagnosis. The patients underwent best-corrected visual acuity (VA) test, color vision (CV) examination, computerized perimetry using the program for low vision assessment, optical coherence tomography (OCT). RESULTS Over the course of the follow-up (60 months or longer) HON patients were revealed to have higher VA in c.152A>G and m.14484T>C mutations compared to mutations m.11778G>A and m.3460G>A. The final VA 0.5 or higher in patients with c.152A>G and m.14484T>C mutations in 54 and 71% of cases, and only in 6 and 13% of cases — with m.11778G>A and m.3460G>A mutations. Direct correlation was determined between minimal VA in the first year after disease onset and the final VA (K=0.67; pG and m.14484T>C mutations have better prognosis compared to LHON caused by m.11778G>A and m.3460G>A mutations. Vision recovery prognosis is worse in patients who had significant decrease of visual acuity at the disease onset. OCT findings reveal preservation of visual functions in all mutations.